Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|10|E43-E52

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.10, 2015-10, pp. : E43-E52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 85-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3631-3638

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 422-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2265-2274

John Wiley & Sons Inc

Access to resources Recommend Favorite